Department of ENT, Royal National ENT & Eastman Dental Hospitals, London WC1E 6DG, UK.
Ear Institute, University College London, London WC1X 8EE, UK.
Medicina (Kaunas). 2022 Feb 25;58(3):348. doi: 10.3390/medicina58030348.
: Since the COVID-19 pandemic, the number of cases of post-infectious olfactory dysfunction (PIOD) has substantially increased. Despite a good recovery rate, olfactory dysfunction (OD) becomes persistent in up to 15% of cases and further research is needed to find new treatment modalities for those patients who have not improved on currently available treatments. Social media has emerged as a potential avenue for patient recruitment, but its role in recruiting patients with smell dysfunction remains unexplored. We conducted a survey using the AbScent Facebook page to evaluate the feasibility of using this platform for future studies on smell dysfunction. : Between 26 October and 4 November 2021, we conducted an online survey to evaluate propensity of patients with PIOD who would be willing to participate in research studies on smell dysfunction. : Sixty-five subjects were surveyed with a response rate of 90.7%. The median visual analogue scale (VAS) for sense of smell was 0 at infection and 2 at survey completion. The median length of OD was 1.6 years, and the main cause of OD was SARS-CoV-2 (57.6%). Parosmia was reported in 41 subjects (69.5%) whilst phantosmia in 22 (37.3%). The median length of olfactory training (OT) was 6 months but subjectively effective in 15 subjects (25.4%). Twenty-seven subjects (45.8%) tried other medications to improve olfaction, but only 6 participants (22.2%) reported an improvement. All subjects expressed their propensity to participate in future studies with most of them (38; 64.4%) willing to be enrolled either in medical and surgical studies or to be part of a randomised study design (11; 18.6%). : Using the AbScent Facebook platform we successfully selected a population of subjects with persistent and severe OD that have failed to improve on available treatments and are willing to participate in further clinical trials.
自 COVID-19 大流行以来,感染后嗅觉功能障碍(PIOD)的病例数量大幅增加。尽管恢复率良好,但嗅觉障碍(OD)在多达 15%的病例中持续存在,因此需要进一步研究为那些在现有治疗方法上没有改善的患者寻找新的治疗方法。社交媒体已成为患者招募的潜在途径,但它在招募嗅觉障碍患者方面的作用仍未得到探索。我们使用 AbScent Facebook 页面进行了一项调查,以评估该平台在未来嗅觉障碍研究中的可行性。
在 2021 年 10 月 26 日至 11 月 4 日期间,我们进行了一项在线调查,以评估 PIOD 患者参与嗅觉障碍研究的意愿。
共有 65 名受试者接受了调查,回应率为 90.7%。嗅觉的中位数视觉模拟量表(VAS)在感染时为 0,在调查完成时为 2。OD 的中位数持续时间为 1.6 年,OD 的主要病因是 SARS-CoV-2(57.6%)。41 名受试者(69.5%)报告有幻嗅,22 名受试者(37.3%)报告有幻嗅。嗅觉训练(OT)的中位数持续时间为 6 个月,但主观上有 15 名受试者(25.4%)有效。27 名受试者(45.8%)尝试了其他药物来改善嗅觉,但只有 6 名参与者(22.2%)报告有所改善。所有受试者都表示愿意参与未来的研究,其中大多数(38 名;64.4%)愿意参加医学和外科研究,或参与随机研究设计(11 名;18.6%)。
我们使用 AbScent Facebook 平台成功地选择了一群持续性和严重 OD 的受试者,他们在现有治疗方法上没有改善,愿意参与进一步的临床试验。